University of Cambridge > > euroscicon > Stem Cells and Bioprocessing

Stem Cells and Bioprocessing

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Speaker to be confirmed.

Harnessing the immense therapeutic and research potential of stem cells requires extensive quality control to ensure the identity, quality, and safety of the cell. Stem cells of different origin and their capability to differentiate towards a specific phenotype as well as tissue engineered constructs are dependent of all kinds of bioprocesses including cultivation media, biomechanical conditions and purification techniques. All topics dealing with the optimization and analysis of processes leading to defined in vitro cultivated cell lines and engineered tissues – with a special focus on bioreactors – will be discussed in this session. This event has CPD accreditation.

To view the pdf agenda please click on

This event is part of The 2014 Tissue Engineering Congress

Meeting Chair: Dr Johanna Buschmann, Head of Research Laboratories, University Hospital Zurich, Plastic Surgery, Switzerland

Who Should Attend: All those interested in the use of stem cells for tissue engineered constructs should find this meeting extremely valuable.

The deadline for abstract submissions for oral presentation is March 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at:

Talks include Proliferation of ASC -derived endothelial cells in a 3D electrospun mesh: Impact of bone-biomimetic nanocomposite and co-culture with ASC -derived osteoblasts. Dr Johanna Buschmann, Head of Research Laboratories, University Hospital Zurich, Plastic Surgery, Switzerland

Bioreactors for tissue engineering Dr Marianne Ellis, University of Bath, UK

Development of scalable microcarrier-based tissue engineering Dr Ivan Wall, Lecturer in Regenerative Medicine Bioprocessing, University College London, UK

Immune Regulation by Mesenchymal Stromal Cells from Umbilical Cord Dr John Girdlestone, NHS Blood and Transplant, UK

Additional confirmed speakers Professor Athanasios Mantalaris, Imperial College London, UK Dr Farlan Veraitch, Department of Biochemical Engineering, University College London, UK

Keywords: Clinical Trial Partnerships, stem cells, banking,manufacturing,scale-up,GMP, regenerative,IPS, ATM Ps, somatic, stem cells, constructs, human embryonic stem cells, clinical grade, cGMP, macular degeneration, retinal pigment epithelium, RPE , AMD, multiple sclerosis, neurodegeneration,cell therapy, clinician-scientist, stem cell research, translation, career path, Stem Cells, Embryonic, clinical application, Manufacture, Cell Therapies, Process,umbilical cord; cord blood; mesenchymal; biobanking; cell therapy, Stem cell, dynamic culture, differentiation, biomechanics, bioreactor, Biochemical Engineering; Bioreactors; Bone Regeneration; Cultured Meat; Liver Toxicity Mode

This talk is part of the euroscicon series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity